<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE paragraph
  PUBLIC "-//IFRS//DTD DITA Paragraph//EN" "../../../../DocTypes/com.ifrs.doctype/dtd/paragraph.dtd">
<paragraph id="IFRS02_43" base="SL34595" principles="no"><paranum>43</paranum><prolog><data name="standard_number" value="IFRS 2"/><data name="paranum" value="43"/></prolog><body><p id="IFRS02_P0129">If no such obligation exists, the entity shall account for the transaction in accordance with the requirements applying to <xref base="SL141004" href="IFRS02_APPA.dita#IFRS02_APPA/IFRS02_P0246">equity&#x2011;settled share&#x2011;based payment transactions<ph outputclass="def_xref"><xref keyref="GLOSSARY_DI0106"/></ph></xref>, in <xref id="IFRS02_X0228" base="F753212" href="IFRS02_g10-29.dita#IFRS02_g10-29/IFRS02_g10-29_TI">paragraphs 10&#x2013;29</xref>. Upon settlement: </p><ol id="IFRS02_L0009" base="SL140915" type="lower-alpha"><li><li_value>(a)</li_value> <p id="IFRS02_P0130" base="SL140917">if the entity elects to settle in cash, the cash payment shall be accounted for as the repurchase of an equity interest, ie as a deduction from equity, except as noted in (c) below.</p></li><li><li_value>(b)</li_value> <p id="IFRS02_P0131" base="SL140919">if the entity elects to settle by issuing <xref base="SL140998" href="IFRS02_APPA.dita#IFRS02_APPA/IFRS02_P0243">equity instruments<ph outputclass="def_xref"><xref keyref="GLOSSARY_DI0102"/></ph></xref>, no further accounting is required (other than a transfer from one component of equity to another, if necessary), except as noted in (c) below.</p></li><li><li_value>(c)</li_value> <p id="IFRS02_P0132" base="SL140921">if the entity elects the settlement alternative with the higher <xref base="SL141007" href="IFRS02_APPA.dita#IFRS02_APPA/IFRS02_P0249">fair value<ph outputclass="def_xref"><xref keyref="GLOSSARY_DI0119"/></ph></xref>, as at the date of settlement, the entity shall recognise an additional expense for the excess value given, ie the difference between the cash paid and the fair value of the equity instruments that would otherwise have been issued, or the difference between the fair value of the <xref base="SL140998" href="IFRS02_APPA.dita#IFRS02_APPA/IFRS02_P0243">equity instruments<ph outputclass="def_xref"><xref keyref="GLOSSARY_DI0102"/></ph></xref> issued and the amount of cash that would otherwise have been paid, whichever is applicable.</p></li></ol></body></paragraph>